Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2024-09-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
上海市金茂律师事务所关于和元生物技术（上海）股份有限公司2024年第二次临时股东大会之法律意见书
Regulatory Filings
2024-09-19 Chinese
海通证券股份有限公司关于和元生物技术（上海）股份有限公司2024年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2024年半年度持续督导跟踪报告" which translates to "2024 Semi-Annual Continuous Supervision Follow-up Report". It is issued by the sponsor (保荐机构) Haitong Securities for the company Heyuan Biotechnology (和元生物技术). The content includes detailed financial data for the first half of 2024, risk disclosures, business and technical updates, R&D progress, and compliance with fundraising usage. The document is comprehensive, covering a half-year period with substantive financial and operational information. It is not a brief announcement or a certification letter but a detailed report on the company's half-year performance and sponsor's supervision activities. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive analysis. Therefore, the correct classification is IR with high confidence. H1 2024
2024-09-12 Chinese
股东减持计划时间届满暨权益变动达1%的公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement about the completion of a shareholder share reduction plan and the resulting changes in shareholding percentages. It includes specifics about the shareholders involved, the number of shares reduced, the time period of the reduction, and the impact on shareholding proportions. The document does not contain financial statements, earnings data, or management discussion of financial results. It is not an annual or interim report, nor is it a call transcript or audit report. It is a regulatory disclosure about a significant shareholding change by major shareholders, including details on the reduction plan and its implementation results. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is about 4937 characters, which is sufficient for a full notification rather than a brief announcement. Therefore, the correct classification is MRQ with high confidence.
2024-09-09 Chinese
2024年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2024 年第二次临时股东大会会议资料" which translates to "2024 Second Extraordinary General Meeting (EGM) Meeting Materials." It contains detailed meeting instructions, agenda, and a specific proposal regarding changes in the board of directors. The content includes procedural rules for the meeting, voting instructions, and a proposal about director resignation and nomination. There is no financial data or earnings information, nor is it a transcript or a report publication announcement. The document is clearly materials shared for a shareholders' meeting, specifically an extraordinary general meeting, focusing on board changes. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings (AGM or EGM). The document length is under 5,000 characters but contains substantive meeting materials, not just an announcement of a report. Hence, the classification is AGM-R with high confidence.
2024-09-09 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2024 年半年度报告摘要" which translates to "2024 Semi-Annual Report Summary." It contains detailed financial data for the half-year period, including total assets, net profit, revenue, and shareholder information. The document explicitly states it is a summary of the half-year report and references the full half-year report for more details. The presence of substantive financial data and management discussion indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3513 characters, which is relatively short but contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-28 Chinese
关于召开2024年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of a 2024 half-year performance explanation meeting (业绩说明会) by the company 和元生物技术（上海）股份有限公司. It references that the company has already disclosed its 2024 half-year report on August 29, 2024, and the meeting is intended to provide investors with a detailed explanation and interactive Q&A session regarding the half-year financial results. The document does not contain actual financial statements or substantive financial data but rather informs about the upcoming investor presentation event. Given the content and length (1533 characters), this is not the interim report itself but an announcement of an investor presentation related to the interim results. Therefore, the most appropriate classification is Investor Presentation (IP).
2024-08-28 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.